Those classifications also parallel the established clinical- and histological-based classifications, with basal-like representing ER-/Her2-cancers, Her-2 enriched representing ER-/Her2+, and normal-like and luminal A/B subtypes representing ER+. The gene discussed is ERBB2; the disease is cancer.